Organon’s MIUDELLA FDA Review Advances Hormone-Free IUD
Jersey City, New Jersey, September 15, 2026 Organon has announced that the U.S. Food and Drug Administration (FDA) has...
Reproductive Health
Advertisement
Lupin Wins FDA Approval for Sodium Zirconium Cyclosilicate
Mumbai, India & Naples, Florida, USA, August 10, 2026 Lupin Limited has announced that it has received U.S. Food...
Seegene Advances Comprehensive HPV and STI PCR Screening
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
Telomir Pharmaceuticals Publishes Telomir-Zn Cancer Data
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Revvity Launches SuperFlex Prenatal Screening System
Waltham, Mass., August 10, 2026 Revvity, Inc. announced the launch of its SuperFlex™ prenatal screening system, a compact, CE-IVDR...
Advertisements
Viatris Wins U.S. FDA Approval for Gwyn Lo Contraceptive
PITTSBURGH, July 29, 2026 Viatris Inc. has received U.S. Food and Drug Administration (FDA) approval for Gwyn Lo™ (norelgestromin...
Organon Completes Global MIUDELLA® Licensing Agreement
JERSEY CITY, N.J., June 22, 2026 Organon has completed a global licensing agreement with Sebela Pharmaceuticals for MIUDELLA®, a...
FDA Authorizes Signati Medical’s Multi-Center Trial for Separo System
PROVIDENCE, Rhode Island, USA, June 2, 2026 Signati Medical has achieved a significant regulatory milestone after receiving U.S. Food...
Advertisement
